Sort
15,440 grants matching “organoids”
Molecular Cytology
$613,728Murray Tipping · Sloan-Kettering Inst Can Research · P30 · FY2025 · CA
Genomic Editing & Screening
$613,727Ralph J. Garippa · Sloan-Kettering Inst Can Research · P30 · FY2025 · CA
Elucidating the evolution of Krt8+ alveolar cells to Kras-mutant lung preneoplasia and cancer
$613,551Humam Kadara · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Role of fibroblastic stromal cells and notch signaling in tissue inflammation in RA and SLE
$613,480Michael B Brenner · Brigham And Women'S Hospital · P01 · FY2023 · AI
"DNMT and TET1 reprogramming as a targetable mechanism of resistance in advanced prostate cancer"
$613,243David S. Rickman · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
IMAGINE: Intestinal Metaplasia And Gastritis INtErception Study
$613,207Katherine Garman · Duke University · R01 · FY2025 · DK
Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer
$613,187Amir Zarrinpar · University Of California, San Diego · U01 · FY2023 · CA
Mechanisms of Mammalian Genetic Hearing Loss
$613,002Rick F Nelson · Indiana University Indianapolis · R01 · FY2023 · DC
Project 1 - Evolutionary and ecological dynamics of tumor-host interactions
$612,755Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2015 · CA
Mechanisms of telomere-induced disease: Role of intestinal malabsorption, barrier dysfunction and dsybiosis.
$612,556Ergun Sahin · Baylor College Of Medicine · R01 · FY2024 · DK
Regulation of epithelial function using targeted nanowires
$612,502Michael H. Koval · Emory University · R01 · FY2025 · HL
Regulation of epithelial function using targeted nanowires
$612,502Michael H. Koval · Emory University · R01 · FY2023 · HL
Identification of Genetic and Molecular Bases of Derived Phenotypes in Primate Brain Development
$612,464Nenad Sestan · Yale University · R01 · FY2021 · HG
Dissecting a novel tumor-promoting axis in cholangiocarcinoma
$612,322Daniela Sia · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
Dissecting a novel tumor-promoting axis in cholangiocarcinoma
$612,322Daniela Sia · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Single Cell Profiling To Define Biomarkers Of Photoreceptor Dysfunction After Gene Editing Within PSC-Derived Organoids
$611,987Krishanu Saha · University Of Wisconsin-Madison · U01 · FY2020 · EY
Single Cell Profiling To Define Biomarkers Of Photoreceptor Dysfunction After Gene Editing Within PSC-Derived Organoids
$611,987Krishanu Saha · University Of Wisconsin-Madison · U01 · FY2022 · EY
Single Cell Profiling To Define Biomarkers Of Photoreceptor Dysfunction After Gene Editing Within PSC-Derived Organoids
$611,987Krishanu Saha · University Of Wisconsin-Madison · U01 · FY2021 · EY
Defining and perturbing gene regulatory dynamics in the developing human brain
$611,882William James Greenleaf · Stanford University · R01 · FY2023 · NS
Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC
$611,606Christine L. Hann · Johns Hopkins University · U01 · FY2020 · CA
Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC
$611,606Luigi Marchionni · Johns Hopkins University · U01 · FY2018 · CA
Integration of mononuclear phagocytes into the human gastrointestinal GOFlowChip for investigation of luminal antigen sampling
$611,545Seth T Walk · Montana State University - Bozeman · U01 · FY2020 · EB
Integration of mononuclear phagocytes into the human gastrointestinal GOFlowChip for investigation of luminal antigen sampling
$611,538Seth T Walk · Montana State University - Bozeman · U01 · FY2022 · EB
Integration of mononuclear phagocytes into the human gastrointestinal GOFlowChip for investigation of luminal antigen sampling
$611,538Seth T Walk · Montana State University - Bozeman · U01 · FY2023 · EB
Optical imaging of pancreas cancer organoids for drug development and personalized treatment
$611,452Melissa Caroline Skala · Morgridge Institute For Research, Inc. · R01 · FY2019 · CA